Hypermethylation of SHISA3 Promotes Nasopharyngeal Carcinoma Metastasis by Reducing SGSM1 Stability.

Abstract:

:Altered DNA methylation is a key feature of cancer, and aberrant methylation is important in nasopharyngeal carcinoma (NPC) development. However, the methylation mechanisms underlying metastasis of NPC remain unclear. Analyzing data from public databases and conducting our own experiments, we report here that promoter hypermethylation of SHISA3 is common and contributes to the downregulation of this gene in many types of tumors, including NPC. SHISA3 suppressed NPC cell invasion and metastasis in vitro and in vivo by impeding the E3 ubiquitin ligase tripartite motif containing 21 (TRIM21)-mediated ubiquitination and degradation small G protein signaling modulator 1 (SGSM1) and by inhibiting the MAPK pathway activation. Silencing SGSM1 abrogated the inhibitory effect of SHISA3 on NPC cell migration and invasion. This newly identified SHISA3-TRIM21-SGSM1 axis could be a novel therapeutic target in NPC. SIGNIFICANCE: These findings highlight the mechanism by which a newly identified tumor suppressor SHISA3 suppresses invasion and metastasis of nasopharyngeal carcinoma.

journal_name

Cancer Res

journal_title

Cancer research

authors

Zhang J,Li YQ,Guo R,Wang YQ,Zhang PP,Tang XR,Wen X,Hong XH,Lei Y,He QM,Yang XJ,Sun Y,Ma J,Liu N

doi

10.1158/0008-5472.CAN-18-1754

subject

Has Abstract

pub_date

2019-02-15 00:00:00

pages

747-759

issue

4

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-18-1754

journal_volume

79

pub_type

杂志文章
  • Immunotherapy of liver metastases of human gastric carcinoma with interleukin 2-activated natural killer cells.

    abstract::To better understand the events occurring during immunotherapy of liver metastases with effector cells, we have developed a clinically relevant animal model in which both effector-tumor cell interactions and survival can be evaluated. A cell line of human gastric carcinoma (HR) metastatic to the liver has been establi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yasumura S,Lin WC,Hirabayashi H,Vujanovic NL,Herberman RB,Whiteside TL

    更新日期:1994-07-15 00:00:00

  • Expansion of tumor-specific CD8+ T cell clones in patients with relapsed myeloma after donor lymphocyte infusion.

    abstract::Donor lymphocyte infusions (DLI) provide effective therapy for patients with multiple myeloma who have relapsed after allogeneic bone marrow transplantation. However, the immunological mechanisms of the graft-versus-myeloma (GVM) effect have not been defined, and the target antigens of this response have not been iden...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Orsini E,Bellucci R,Alyea EP,Schlossman R,Canning C,McLaughlin S,Ghia P,Anderson KC,Ritz J

    更新日期:2003-05-15 00:00:00

  • DeltaNp63alpha confers tumor cell resistance to cisplatin through the AKT1 transcriptional regulation.

    abstract::Strategies to address resistance to platin drugs are greatly needed in human epithelial cancers (e.g., ovarian, head/neck, and lung) where platins are used widely and resistance occurs commonly. We found that upon ΔNp63α overexpression, AKT1 and phospho-AKT1 levels are upregulated in cancer cells. Investigations using...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-1481

    authors: Sen T,Sen N,Brait M,Begum S,Chatterjee A,Hoque MO,Ratovitski E,Sidransky D

    更新日期:2011-02-01 00:00:00

  • Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition.

    abstract::Most cancer cells utilize aerobic glycolysis, and activation of the phosphoinositide 3-kinase/Akt/mTOR pathway can promote this metabolic program to render cells glucose dependent. Although manipulation of glucose metabolism may provide a means to specifically eliminate cancer cells, mechanistic links between cell met...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-4531

    authors: Coloff JL,Macintyre AN,Nichols AG,Liu T,Gallo CA,Plas DR,Rathmell JC

    更新日期:2011-08-01 00:00:00

  • Monoclonal antibodies to an ectopically expressed alkaline phosphatase in a human malignant cell line.

    abstract::The D98/AH-2 cell line (a subline of HeLa) expresses a form of alkaline phosphatase (ALP) which closely resembles the adult and fetal intestinal forms of ALP. To characterize this ectopic form of ALP, four monoclonal antibodies were raised against D98/AH-2 ALP, and their binding with ALPs from D98/AH-2 cells, placenta...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wray LK,Harris H

    更新日期:1983-02-01 00:00:00

  • Epithelial-to-Mesenchymal and Mesenchymal-to-Epithelial Transition in Mesenchymal Tumors: A Paradox in Sarcomas?

    abstract::The epithelial-to-mesenchymal transition (EMT) is a reversible process comprised of various subprograms via which epithelial cells reduce their intercellular adhesions and proliferative capacity while gaining a mesenchymal phenotype with increased migratory and invasive properties. This process has been well described...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-17-0032

    authors: Sannino G,Marchetto A,Kirchner T,Grünewald TGP

    更新日期:2017-09-01 00:00:00

  • CEP1612, a dipeptidyl proteasome inhibitor, induces p21WAF1 and p27KIP1 expression and apoptosis and inhibits the growth of the human lung adenocarcinoma A-549 in nude mice.

    abstract::The ubiquitin proteasome system is responsible for the proteolysis of important cell cycle and apoptosis-regulatory proteins. In this paper we report that the dipeptidyl proteasome inhibitor, phthalimide-(CH2)8CH-(cyclopentyl) CO-Arg(NO2)-Leu-H (CEP1612), induces apoptosis and inhibits tumor growth of the human lung c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sun J,Nam S,Lee CS,Li B,Coppola D,Hamilton AD,Dou QP,Sebti SM

    更新日期:2001-02-15 00:00:00

  • Cachectic effects of recombinant human tumor necrosis factor in rats.

    abstract::Treatment of rats with either intermittent bolus i.v. injections or continuous i.v. infusions of the same sublethal daily dose of tumor necrosis factor (TNF) results in decreased food intake and decreased nitrogen balance compared to saline-treated control rats. After 4 days of treatment, rats treated with intermitten...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Darling G,Fraker DL,Jensen JC,Gorschboth CM,Norton JA

    更新日期:1990-07-01 00:00:00

  • Epstein-Barr virus infections in hairy cell leukemia patients in the presence of complement-dependent neutralizing antibody.

    abstract::Immune system status was characterized in patients with hairy cell leukemia (HCL) with respect to explaining their chronic or recurrent infections with Epstein-Barr virus. Measures of cellular immune responsiveness for a group of 11 HCL patients were, in general, decreased when expressed as the proportion of tested pa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sairenji T,Sullivan JL,Sakamoto K,Spiro RC,Katayama I,Humphreys RE

    更新日期:1985-01-01 00:00:00

  • Ras oncogene-induced sensitization to 1-beta-D-arabinofuranosylcytosine.

    abstract::Human tumor cells containing ras oncogenes display enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine (Ara-C) and other deoxycytidine analogues (H-M. Koo, et al., Cancer Res., 56: 5211-5216, 1996). Human tumor cell lines with or without a ras oncogene as well as a pair of isogenic cell lines with one containing...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Koo HM,McWilliams MJ,Alvord WG,Vande Woude GF

    更新日期:1999-12-15 00:00:00

  • Morphological and functional differentiation of Kirsten murine sarcoma virus-transformed rat adrenocortical cell lines.

    abstract::This study was undertaken to examine relationships of the phenotype of malignant cells to target cell properties and to events early in the transformation process. Eighteen transformed lines were obtained by Kirsten murine sarcoma virus infection of cells from adrenal glands of rats ages 4 to 30 weeks, at first or sec...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Auersperg N,Wan MW,Sanderson RA,Wong KS,Mauldin D

    更新日期:1981-05-01 00:00:00

  • Systemic DNA damage related to cancer.

    abstract::The importance of bystander effects is becoming more appreciated, as studies show they may affect the course of cancer and other chronic diseases. The term "bystander effects" refers to changes in naïve cells sharing the same milieu with cells that have been damaged. Bystander cells may be in contact with, or distant ...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-10-4579

    authors: Martin OA,Redon CE,Nakamura AJ,Dickey JS,Georgakilas AG,Bonner WM

    更新日期:2011-05-15 00:00:00

  • Induction of covalent DNA modifications and micronucleated erythrocytes by 4-nitroquinoline 1-oxide in adult and fetal mice.

    abstract::Pregnancy and development are known to modify carcinogenesis. Little is known about the mechanism for the modulation. These studies investigated the relative sensitivity of nonpregnant, pregnant, and fetal mice to the induction of covalent DNA modifications and micronucleated erythrocytes by 4-nitroquinoline 1-oxide (...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lu LJ,Baxter JR,Wang MY,Harper BL,Tasaka F,Kohda K

    更新日期:1990-10-01 00:00:00

  • Phase I clinical study of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641).

    abstract::Between February 1987 and July 1988, 45 patients with advanced refractory cancer were treated with LY186641, a diarylsulfonylurea that has shown a broad spectrum of activity in preclinical testing. Patients received a weekly p.o. dose of LY186641 for 6 consecutive weeks; responding and stable patients continued weekly...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hainsworth JD,Hande KR,Satterlee WG,Kuttesch J,Johnson DH,Grindey G,Jackson LE,Greco FA

    更新日期:1989-09-15 00:00:00

  • Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-g

    abstract::Cyclooxygenase (COX)-2 and vascular endothelial growth factor (VEGF) are significantly associated with tumor growth and metastasis. Here we show that phorbol ester-mediated induction of VEGF and COX-2 expression in colon carcinoma cells is inhibited by 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)). This cyclop...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-0849

    authors: Grau R,Iñiguez MA,Fresno M

    更新日期:2004-08-01 00:00:00

  • Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene.

    abstract::Approximately 10% of gastric adenocarcinomas worldwide are associated with human EBV. These carcinomas generally do not express the latent membrane protein 1 (LMP1), the major known EBV oncogene. Recently, another EBV gene [ie., BARF1 (BamHI A rightward open reading frame)] was shown to have transforming and immortali...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: zur Hausen A,Brink AA,Craanen ME,Middeldorp JM,Meijer CJ,van den Brule AJ

    更新日期:2000-05-15 00:00:00

  • Clinical pharmacokinetics of vinblastine by continuous intravenous infusion.

    abstract::Vinblastine (VLB) is moderately active clinically against advanced breast cancer. Since VLB is extensively taken up by platelets and thus only partially available to tumor cells, to enhance the therapeutic index of VLB we have therefore administered this agent by continuous i.v. infusion to patients with advanced brea...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lu K,Yap HY,Loo TL

    更新日期:1983-03-01 00:00:00

  • Overexpression of transforming growth factor alpha overrides the glucocorticoid-mediated suppression of Con8 mammary tumor cell growth in vitro and in vivo.

    abstract::In a preceding paper (D. B. Alexander et al., Cancer Res., 53: 1808-1815, 1993), we demonstrated that the in vitro glucocorticoid inhibition of Con8 mammary tumor cell growth is accompanied by the disruption of a transforming growth factor alpha (TGF-alpha) autocrine loop. This growth suppression response functions in...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Goya L,Alexander DB,Webster MK,Kern FG,Guzman RC,Nandi S,Firestone GL

    更新日期:1993-04-15 00:00:00

  • Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.

    abstract::Thioguanine and mercaptopurine are prodrugs requiring conversion into thiopurine nucleotides to exert cytotoxicity. Thiopurine S-methyltransferase (TPMT), an enzyme subject to genetic polymorphism, catabolizes thiopurines into inactive methylated bases, but also produces methylthioguanine nucleotides and methylmercapt...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dervieux T,Blanco JG,Krynetski EY,Vanin EF,Roussel MF,Relling MV

    更新日期:2001-08-01 00:00:00

  • Differential EphA2 epitope display on normal versus malignant cells.

    abstract::The EphA2 receptor tyrosine kinase is overexpressed in many different types of human cancers where it functions as a powerful oncoprotein. Dramatic changes in the subcellular localization and function of EphA2 have also been linked with cancer, and in particular, unstable cancer cell-cell contacts prevent EphA2 from s...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Coffman KT,Hu M,Carles-Kinch K,Tice D,Donacki N,Munyon K,Kifle G,Woods R,Langermann S,Kiener PA,Kinch MS

    更新日期:2003-11-15 00:00:00

  • The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.

    abstract::Predisposition to prostate cancer has a genetic component, and there are reports of familial clustering of breast and prostate cancer. Two highly penetrant genes that predispose individuals to breast cancer (BRCA1 and BRCA2) are known to confer an increased risk of prostate cancer of about 3-fold and 7-fold, respectiv...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gayther SA,de Foy KA,Harrington P,Pharoah P,Dunsmuir WD,Edwards SM,Gillett C,Ardern-Jones A,Dearnaley DP,Easton DF,Ford D,Shearer RJ,Kirby RS,Dowe AL,Kelly J,Stratton MR,Ponder BA,Barnes D,Eeles RA

    更新日期:2000-08-15 00:00:00

  • Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.

    abstract::Photodynamic therapy (PDT) is now an approved therapeutic modality, and induction of vascular endothelial growth factor (VEGF) following subcurative PDT is of concern as VEGF may provide a survival stimulus to tumors. The processes that limit the efficacy of PDT warrant investigation so that mechanism-based interventi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-0604

    authors: Solban N,Selbo PK,Sinha AK,Chang SK,Hasan T

    更新日期:2006-06-01 00:00:00

  • Phosphatidylinositol 3'-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells.

    abstract::The development of androgen-independent growth in advanced carcinoma of the prostate (CaP) is associated with poor prognosis and few therapeutic options. Chemotherapeutic drugs offer the afflicted patient palliative benefits, but these are short-lived because of the chemoresistant nature of hormone-refractory prostate...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-1612

    authors: Lee JT Jr,Steelman LS,McCubrey JA

    更新日期:2004-11-15 00:00:00

  • CD99 engagement: an effective therapeutic strategy for Ewing tumors.

    abstract::CD99 is a Mr 32,000 transmembrane molecule that shows a high level of expression on cells of the hemopoietic system as well as on Ewing tumor cells. Within the hematopoietic system, CD99 has been implicated in cell adhesion and cell death, participating in this way in the differentiation of T-cell precursors. In this ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Scotlandi K,Baldini N,Cerisano V,Manara MC,Benini S,Serra M,Lollini PL,Nanni P,Nicoletti G,Bernard G,Bernard A,Picci P

    更新日期:2000-09-15 00:00:00

  • ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.

    abstract::Chromatin coregulators are important factors in tumorigenesis and cancer progression. ANCCA is an AAA+ ATPase and a bromodomain-containing nuclear coactivator for the estrogen and androgen receptors that is crucial for assembly of chromatin-modifying complexes and proliferation of hormone-responsive cancer cells. In t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-1199

    authors: Kalashnikova EV,Revenko AS,Gemo AT,Andrews NP,Tepper CG,Zou JX,Cardiff RD,Borowsky AD,Chen HW

    更新日期:2010-11-15 00:00:00

  • PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation.

    abstract::Tumor relapses remain a serious problem after allogeneic stem cell transplantation (alloSCT), despite the long-term persistence of minor histocompatibility antigen (MiHA)-specific memory CD8(+) T cells specific for the tumor. We hypothesized that these memory T cells may lose their function over time in transplanted p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-0108

    authors: Norde WJ,Maas F,Hobo W,Korman A,Quigley M,Kester MG,Hebeda K,Falkenburg JH,Schaap N,de Witte TM,van der Voort R,Dolstra H

    更新日期:2011-08-01 00:00:00

  • Specific binding to protein kinase C by ingenol and its induction of biological responses.

    abstract::We have examined the ability of ingenol to bind to and activate protein kinase C and to induce similar responses to the phorbol esters in biological systems. The rationale was that ingenol possesses the critical functionalities of the phorbol ester pharmacophore with the exception of the hydrophobic domain; it might t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hasler CM,Acs G,Blumberg PM

    更新日期:1992-01-01 00:00:00

  • Subcellular localization of blood group Leb carbohydrate antigen (MSN-1-reactive antigen) in endometrial cancer cells.

    abstract::MSN-1 is a monoclonal antibody, which was raised by immunizing mice with a human endometrial cancer cell line, SNG-II. The MSN-1 specifically recognizes a blood group carbohydrate antigen, Leb. We investigated the subcellular and suborganellar localization of the MSN-1-reactive carbohydrate antigens in the endometrial...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Susumu N,Kawakami H,Aoki D,Hirano H,Nozawa S

    更新日期:1993-08-01 00:00:00

  • Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro.

    abstract::We studied the effects of interleukin-1 alpha (IL-1) and interleukin-6 (IL-6) on MCF-7 breast cancer cells to determine whether these cytokines act additively/synergistically to alter cell growth and metabolism. We found that IL-1 alone (1000 units/ml) inhibited cell growth to a greater degree (83.8%) than IL-6 alone ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Danforth DN Jr,Sgagias MK

    更新日期:1993-04-01 00:00:00

  • Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer.

    abstract::When pancreatic cancer cannot be removed surgically, patients frequently experience morbidity and death from progression of their primary tumor. Radiation therapy (RT) cannot yet substitute for an operation because radiation causes fatal bleeding and ulceration of the nearby stomach and intestines before achieving tum...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-1785

    authors: Fujimoto TN,Colbert LE,Huang Y,Molkentine JM,Deorukhkar A,Baseler L,de la Cruz Bonilla M,Yu M,Lin D,Gupta S,Cabeceiras PK,Kingsley CV,Tailor RC,Sawakuchi GO,Koay EJ,Piwnica-Worms H,Maitra A,Taniguchi CM

    更新日期:2019-05-01 00:00:00